Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology

Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology

Synthesis Of Nursing Practice

Synthesis Of Nursing Practice

Left-sided heart failure: Nursing process (ADPIE)
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Normal heart sounds
Abnormal heart sounds
Anatomy of the heart
Congenital heart defects: Clinical
Cardiac conduction system
Post-COVID syndrome: Heart, lungs and clotting
Heart blocks: Pathology review
Aortic aneurysm: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Myocardial infarction (MI): Nursing process (ADPIE)
Pericardial effusion and cardiac tamponade: Nursing process (ADPIE)
Rheumatic heart disease: Nursing process (ADPIE)
Antihyperlipidemics - Statins: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Medications affecting the parathyroid glands: Nursing pharmacology
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Glucocorticoids and mineralocorticoids: Nursing pharmacology
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Urinary tract infections (UTIs): Nursing process (ADPIE)
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Sickle cell disease: Nursing process (ADPIE)
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Blood products: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Plant extracts for chemotherapy: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Alkylating agents: Nursing pharmacology
Hormones and hormone modulators for cancer: Nursing pharmacology
Other antineoplastics: Nursing pharmacology
Antimetabolites: Nursing pharmacology
Platinum-based agents: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Candidiasis: Nursing process (ADPIE)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Applying sterile gloves
Cardioversion
Maintaining an airway
Removing an intravenous line
Venipuncture for blood sampling
Clinical Skills: Abdominal Assessment
Clinical skills: Medication administration - Giving transcutaneous medication
Clinical skills: Patient controlled analgesia
COVID-19: Nursing

Notes

OPHTHALMIC ANTI-INFLAMMATORIES
DRUG NAME
diclofenac, flurbiprofen, ketorolac (Acular), nepafenac (Nevanac)
dexamethasone (Maxidex),  prednisolone (Pred Forte)
emedastine, epinastine
cromolyn, nedocromil (Alocril)
CLASS
Ophthalmic NSAIDs
Ophthalmic corticosteroids
Ophthalmic antihistamines
Ophthalmic mast cell stabilizers
MECHANISM OF ACTION
Decrease the number of inflammatory cells and inhibit inflammatory mediator molecules (e.g., histamines, prostaglandins)
INDICATIONS
  • Allergic conjunctivitis
  • Non-infectious uveitis
  • Postoperative eye inflammation
ROUTE(S) OF ADMINISTRATION
  • TOP
SIDE EFFECTS
  • Headache
  • Increased intraocular pressure
  • Thinning of the cornea
  • Delayed corneal healing
  • Stinging or burning sensation
  • Cataracts (prolonged use)
CONTRA-INDICATIONS AND CAUTIONS
  • None
OPHTHALMIC ANTI-INFECTIVES
DRUG NAME
ciprofloxacin (Ciloxan), erythromycin, gentamicin, (Gentak), levofloxacin, sulfacetamide (Bleph-10), tobramycin (Tobrex), tetracycline (Sumycin, Actisite, Achromycin V)

natamycin (Natacyn)
trifluridine
CLASS
Ophthalmic antibiotics
Ophthalmic antifungals
Ophthalmic antivirals
MECHANISM OF ACTION
Kill or stop growth of bacteria
Kill or stop growth of fungi
Kill or inhibit spread of viruses
INDICATIONS
  • Infectious conjunctivitis
  • Infectious uveitis
  • Infectious blepharitis
  • Infectious keratitis
  • Infectious endophthalmitis
  • Hordeolum (stye)
  • Corneal ulceration
ROUTE(S) OF ADMINISTRATION
  • TOP
SIDE EFFECTS
  • Local skin or eye irritation
  • Non-infectious conjunctivitis
  • Superinfection by resistant organisms
CONTRAINDICATIONS AND CAUTIONS
  • None
NURSING CONSIDERATIONS:
OPHTHALMIC ANTI-INFLAMMATORIES AND ANTI-INFECTIVES
ASSESSMENT AND MONITORING
Ophthalmic anti-inflammatories and anti-infectives
  • Assess for ophthalmic symptoms; e.g., redness, decreased visual acuity, discomfort
  • Review ophthalmic exam results and intraocular pressure test results
  • Monitor for side effects
  • Evaluate the therapeutic response: decreased eye inflammation, resolution of infection
CLIENT EDUCATION
Ophthalmic anti-inflammatories and anti-infectives
  • May experience burning and stinging during application
    • Rest in a dim and quiet environment; applying a warm or cool compress can promote comfort
  • Blurry vision
    • Environmental modifications to prevent falls or injuries
  • Self-administration of the medication
    • Wash hands before and after administration
    • Lie down or sit up with head tilted back
    • Look upward and gently pull down on the lower eyelid to expose the conjunctival sac
    • Administer the prescribed number of drops or amount of ointment
      • Keep applicator tip clean
    • After administration: close eyes for about three minutes
      • For drops: gently press on the inside corner of the closed eye; decreases systemic absorption
      • For multiple eye drops: wait at least five minutes between each administration
      • After administration: blot excess liquid or ointment with a clean tissue
  • Report worsening condition or if their symptoms don’t resolve
Author: Antonia Syrnioti, MD
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Commonly used ophthalmic medications can be broadly divided into two categories: anti-inflammatories and anti-infectives. Ophthalmic anti-inflammatories are a group of medications that are used to treat inflammatory eye conditions, such as allergic conjunctivitis, non-infectious uveitis, and to treat eye inflammation after an ophthalmic procedure.

In contrast, ophthalmic anti-infectives are used to treat infectious eye conditions caused by bacteria, fungi, or viruses. These conditions include infectious conjunctivitis, uveitis, blepharitis, keratitis, and endophthalmitis.

A hordeolum or stye, which is a common bacterial infection of the sebaceous glands of the eyelids, is also treated with ophthalmic anti-infectives. Finally, ophthalmic anti-infectives can also be used in clients with corneal ulceration to prevent infection.

Okay, starting with ophthalmic anti-inflammatories, they can be broadly classified into five groups: NSAIDs, which include diclofenac, flurbiprofen, ketorolac, and nepafenac; as well as corticosteroids, which include dexamethasone and prednisolone; antihistamines, such as emedastine and epinastine; and mast cell stabilizers, including cromolyn and nedocromil.

Finally, a combination of antihistamines and mast cell stabilizers can be used, such as azelastine, epinastine, ketotifen, and olopatadine.

These medications are applied topically in the form of eye drops or ointments. Once applied, they control the eye inflammation by decreasing the number of inflammatory cells, and inhibiting the production and effects of inflammatory mediator molecules, such as histamines or prostaglandins.

Unfortunately, ophthalmic anti-inflammatories can cause side effects, such as headaches, increased intraocular pressure, thinning of the cornea, and a delay in corneal healing. In addition, clients may experience a stinging or burning sensation when the medication is applied.

Finally, prolonged use of these medications has also been associated with the development of cataracts. Luckily, there are no known contraindications for the use of ophthalmic anti-inflammatory medications.

Next are ophthalmic anti-infectives, which can be broken down into three categories: antibiotics, which include ciprofloxacin, erythromycin, gentamicin, levofloxacin, sulfacetamide, tobramycin, and tetracycline; as well as antifungals, such as natamycin; and antivirals, like trifluridine.

These medications are also applied topically in the form of eye drops, or ointments, and they act by respectively killing or stopping the growth of bacteria, fungi, or viruses.

Now, side effects of ophthalmic anti-inflammatories include local skin or eye irritation, which can cause blurred vision or a stinging or burning sensation. Also, ophthalmic anti-inflammatories can increase the risk of non-infectious conjunctivitis or even a superinfection by organisms resistant to these medications. Once again, there are no significant contraindications for ophthalmic anti-infective medications.

Alright, when your client is prescribed an ophthalmic anti-inflammatory or anti-infective, first assess for any ophthalmic symptoms, including redness, discomfort, or decreased visual acuity. Then, be sure to review the results of the most recent ophthalmic exam and intraocular pressure test.

Sources

  1. "Focus on Nursing Pharmacology" LWW (2019)
  2. "Pharmacology" Elsevier Health Sciences (2014)
  3. "Medical-Surgical Nursing" Elsevier Health Sciences (2016)
  4. "Mosby's 2021 Nursing Drug Reference" Mosby (2020)
  5. "Saunders Comprehensive Review for the NCLEX-RN Examination" Saunders (2016)
  6. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)